The long-term effects of pre-treatment with activated protein C in a rat model of compression-induced spinal cord injury

Spinal Cord

Volumn 38, Issue 12, 2000, Pages 754-761

  Taoka, Y ^a,b   Schlag, M G ^c   Hopf, R ^a   Redl, H ^a  

^a LUDWIG BOLTZMANN INSTITUTE FOR EXPERIMENTAL AND CLINICAL TRAUMATOLOGY   (Austria)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c BAXTER INNOVATIONS GMBH   (Austria)

Author keywords

Activated protein C; Lesion size; Motor disturbance Evoked potentials; Spinal cord injury

Indexed keywords

ACTIVATED PROTEIN C; SODIUM CHLORIDE;

ACUTE DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROPHYSIOLOGY; EVOKED BRAIN STEM RESPONSE; EVOKED MUSCLE RESPONSE; EVOKED SOMATOSENSORY RESPONSE; HISTOMETRY; INJURY SCALE; LONG TERM CARE; MALE; MOTOR PERFORMANCE; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD COMPRESSION; SPINAL CORD INJURY;

EID: 0034520388     PISSN: 13624393     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.sc.3101096     Document Type: Article

References (36)

1. The epidemiology and economics of spinal cord injury
2. A randomized, controlled trial of methyl-prednisolone or naloxone in the treatment of acute spinal-cord injury
3. Secondary CNS injury
4. Clinical applications of pharmacologic therapies for spinal cord injury
5. The fine structure of endothelial structures in the microcirculation of experimentally injured feline spinal cords
6. Spinal cord injury in the rat
7. The inhibition of blood coagulation by activated protein C through the selective inactivation of activated factor V
8. The protein C anticoagulant pathway
9. Selective effects of protein C on activation of human monocytes by lipopolysaccharide, interferon-g, or PMA: Modulation of effects on CD11b and CD14 but not CD25 or CD54 induction
10. Activated protein C reduces the severity of compression-induced spinal cord injury in rats by inhibiting activation of leukocytes
11. Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation
12. Involvement of an intracellular adhesion molecule-dependent pathway in the pathogenesis of secondary changes after spinal cord injury in rats
13. Objective clinical assessment of motor function after experimental spinal cord injury in the rat
14. Methods to assess the development and recovery of locomotor function after spinal cord injury
15. Serial recordings of somatosensory and myolectric motor evoked potentials: Role in assessing functional recovery after graded spinal cord injury in the rat
16. Recording of cortically and brainstem evoked muscle potentials in a chronic rat model
17. Effect of mianserin on locomotory function after spinal cord hemisection in rats
18. Locomotor recovery following subtotal spinal cord lesions in a rat model
19. Spinal cord injury produced by consistent mechanical displacement of the cord in rats
20. The relationship among the severity of spinal cord injury, residual neurological function, axon counts, and counts of retrogradely labeled neurons after experimental spinal cord injury
21. Central axons in injured cat spinal cord recover electrophysiological function following remyelination by Schwann cells
22. Secondary injury mechanisms in acute spinal cord injury
23. Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection
24. Axonal regeneration in the rat spinal cord produced by an antibody against myelin-associated neurite growth inhibitors
25. Spinal cord repair in adult paraplegic rats: Partial restoration of hind limb function
26. Cellular delivery of neurotrophin-3 promotes corticospinal axonal growth and partial functional recovery after spinal cord injury
27. Activated protein C attenuates endotoxin-induced pulmonary vascular injury by inhibiting activated leukocytes in rats
28. Pretreatment with activated protein C or active human urinary thrombomodulin attenuates the production of cytokine-induced neutrophil chemoattractant following ischemia/reperfusion in rat liver
29. The endothelial cell protein C receptor aids in host defence against escherichia coli sepsis
30. Possible involvement of interleukin-1 in cyclooxygenase-2 induction after spinal cord injury in rats
31. Prophylactic use of anticoagulant therapy in prevention of pulmonary emboli in one hundred consecutive spinal injury patients
32. Circadian rhythm of pulmonary embolism in patients with acute spinal cord injury
33. 125I-fibrinogen scanning, impedance plethysmography, and venography
34. Sequential change in factor VIII and platelets preceding deep vein thrombosis in patients with spinal cord injury
35. Deep venous thrombosis and pulmonary embolism in patients with acute spinal cord injury: A comparison with non-paralyzed patients immobilized due to spinal fracture
36. Treatment of patients with disseminated intravascular coagulation by protein C